Literature DB >> 5764014

Production rates and metabolic clearance rates of human follicle-stimulating hormone in premenopausal and postmenopausal women.

Y D Coble, P O Kohler, C M Cargille, G T Ross.   

Abstract

The production rates (PR) and the metabolic clearance rates (MCR) of human follicle-stimulating hormone (HFSH) were determined in six pre- and five postmenopausal women. Human FSH (PER-780) labeled with (131)I to specific activities of 50-150 muc/mug was used as a tracer. Both double antibody and trichloroacetic acid (TCA) precipitation techniques were used to determine HFSH-(131)I levels in infusate and plasma. In four of the subjects MCRs measured by both constant infusion and single injection techniques were the same. By constant infusion, plasma HFSH-(131)I levels reached equilibrium between 4-5 hr.MCRs in six premenopausal women were 14.2+/-1.1 (mean +/-SE) ml/min. MCRs in five postmenopausal women were 12.6 +/-1.1 ml/min. Simultaneous HFSH and human luteinizing hormone (HLH) MCRs were determined in a single patient using HFSH-(125)I and HLH-(131)I as tracers by both constant infusion and single injection methods. These studies showed that the MCR of HFSH was 10.8-11.1 ml/min, and the MCR of HLH was 18.5-19.4 ml/min. From these data and previous MCR and PR studies of HLH from this laboratory, it appears that the MCR of HFSH is about one-half that of HLH. Endogenous HFSH and HLH levels were measured by radioimmunoassay. The PRs of HFSH, calculated by the product of endogenous level and MCR, were 146 +/-27mU/min in the premenopausal women and 2141 +/-264 mM/min in the postmenopausal women. 24-hr PRs, based on these results, compared with reports of 24-hr urinary excretions of biologically active HFSH indicate that 3-5% of production is found in urine in biologically active form. After our single injections of HFSH-(131)I, 8-29% was recovered in urine over 24 hr.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5764014      PMCID: PMC322227          DOI: 10.1172/JCI105992

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

1.  THE SEPARATION AND PURIFICATION OF HUMAN LUTEINIZING AND THYROTROPHIC HORMONES.

Authors:  A S HARTREE; W R BUTT; K E KIRKHAM
Journal:  J Endocrinol       Date:  1964-04       Impact factor: 4.286

2.  DETERMINATION OF KINETIC PARAMETERS INA TWO-POOL SYSTEM BY ADMINISTRATION OF ONE OR MORE TRACERS.

Authors:  E GURPIDE; J MANN; E SANDBERG
Journal:  Biochemistry       Date:  1964-09       Impact factor: 3.162

3.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

4.  URINARY EXCRETION OF FOLLICLE-STIMULATING AND LUTEINIZING HORMONES.

Authors:  K L BECKER; A ALBERT
Journal:  J Clin Endocrinol Metab       Date:  1965-07       Impact factor: 5.958

5.  Effect of iodination on the biological activity and metabolism of human luteinizing hormone.

Authors:  P O Kohler; J M Phang; W W Tullner; G T Ross; W D Odell
Journal:  J Clin Endocrinol Metab       Date:  1968-05       Impact factor: 5.958

6.  Radioimmunoassay of human follicle stimulating hormone: bias due to antisera.

Authors:  C M Cargille; D Rodbard; G T Ross
Journal:  J Clin Endocrinol Metab       Date:  1968-09       Impact factor: 5.958

7.  Comparative activities of human urinary postmenopausal gonadotropins.

Authors:  E Rosemberg; W B Lewis
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

8.  The renal clearance of follicle-stimulating and luteinizing hormone in postmenopausal women.

Authors:  P J Keller
Journal:  Acta Endocrinol (Copenh)       Date:  1966-10

9.  Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women.

Authors:  P O Kohler; G T Ross; W D Odell
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

10.  Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies.

Authors:  W D Odell; G T Ross; P L Rayford
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

  10 in total
  14 in total

1.  [Daily fluctuation of the follicle-stimulating (FSH) and luteinizing (LH) hormone in the human plasma].

Authors:  G Leyendecker; B B Saxena
Journal:  Klin Wochenschr       Date:  1970-02-15

Review 2.  Male hypogonadism.

Authors:  W D Odell; R S Swerdloff
Journal:  West J Med       Date:  1976-06

3.  Comprehensive pharmacokinetics of urinary human follicle stimulating hormone in healthy female volunteers.

Authors:  J Y le Cotonnec; H C Porchet; V Beltrami; A Khan; S Toon; M Rowland
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

4.  Metabolic and renal clearance rates of purified human chorionic gonadotropin.

Authors:  R E Wehmann; B C Nisula
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  Hormonal profiles after the menopause.

Authors:  S Chakravarti; W P Collins; J D Forecast; J R Newton; D H Oram; J W Studd
Journal:  Br Med J       Date:  1976-10-02

6.  Metabolic clearance and secretion rates of subunits of human thyrotropin.

Authors:  I A Kourides; R N Re; B D Weintraub; E C Ridgway; F Maloof
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

7.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

8.  The effect of ovariectomy on gonadotropin release.

Authors:  S S Yen; C C Tsai
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

9.  Metabolic clearance rate of radioiodinated human calcitonin in man.

Authors:  R Ardaillou; P Sizonenko; A Meyrier; G Vallée; C Beaugas
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Metabolic clearance and production rates of human thyrotropin.

Authors:  E C Ridgway; B D Weintraub; F Maloof
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.